Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Minocycline superior to placebo for early RA

June 25, 1997

Merck Frosst prepares prodrugs of COX-2 inhibitors

June 23, 1997

Hoechst prepares compounds for degenerative and inflammatory disorders

June 18, 1997

New antiarthritic agent from Czech research institute characterized

June 16, 1997

Oral human immunoglobulin enters clinic for severe RA

June 13, 1997

Clinical safety and efficacy of TS-110 for inflammation and pain

June 12, 1997

Long-term Enbrel safe and effective in RA

June 11, 1997

Development of anti-cytokine antibody product for RA progresses

June 9, 1997

Astra discloses iNOS inhibitors

June 9, 1997

COX-2 inhibitors from Merck Frosst

June 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...